Skip to main content
. 2021 Dec 10;2021(1):254-263. doi: 10.1182/hematology.2021000257

Figure 4.

Figure 4.

How we perform alloHCT for an older patient with a hematologic malignancy. HLA, human leukocyte antigen. *Severe comorbidities: New York Heart Association class 4 heart failure, severe renal dysfunction or end-stage renal disease on dialysis, Child class C liver cirrhosis, Gold stage 4 chronic obstructive lung disease, metastatic solid tumor, dementia, or any comorbidity significantly limiting life expectancy.